Surfactant administration
Surfcath
Description
Surfactant administration catheter for the treatment of premature or full-term high-risk neonates or with respiratory distress syndrome caused by… Read more
Indication
Surfactant administration catheter for the treatment of premature or full-term high-risk neonates or with respiratory distress syndrome caused by pulmonary surfactant deficiency (hyaline membrane disease - MHD).
Product highlights
Site under maintenance
Vygon est en cours de maintenance. Nous serons de retour très bientôt. Merci de votre patience.Description
Surfactant administration catheter for the treatment of premature or full-term high-risk neonates or with respiratory distress syndrome caused by pulmonary surfactant deficiency (hyaline membrane disease - HMD).Surfcath™ is a PEBA transparent catheter of 20 cm long, with an outer diameter of 6Fr and a centimeter marking to guide insertion.
The distal tip of the device is a blunt black tip of 2 cm, bent at 30 degrees. It consists of a flexible part of 15 mm, and an extra-flexible part of 5 mm.
The proximal tip of the Surfcath™ features a Luer-Lock connector.
The tube is curvable and allows the user to manually give the Surfcath™ the desired shape, according to its needs.
References and Features
| Tube | Packaging | |||||
|---|---|---|---|---|---|---|
| Favourites | Code | Ext. Ø Fr | Length cm | Priming volume ml | Units/Box | Units/Case |
| 5590.106 | 6 | 20 | 0.21 | 10 | 200 | |
Additional information
-
Contains Latex No
-
Contains animal product No
-
Pyrogen-free No
Documentation
-
Brochure Surfcath - 2019.06
-
Instructions for use
